but the research collaboration came to an end in 2003. analysts said unilever could launch the new products in 2007. this deal goes a long way to restoring the market faith in phytopharm s pipeline after the pfizer exit said analyst erling refsum at nomura. under the deal production of the hoodia cactus at phytopharm s nursery in south africa will also rise from eight million plants to potentially hundreds of millions said phytopharm chief executive richard dixey. cactus diet deal for phytopharm a slimming aid made from a southern african cactus is set to be developed by uk firm phytopharm and unilever. phytopharm will receive an initial fee of 6.5m from unilever out of a potential total of 21m as well as future royalties on product sales. phytopharm shares jumped 10.7 on the news with analysts saying sales of 600m 309m a year were possible.